Chlamydia trachomatis and human papillomavirus coinfection: Association with p16INK4a and Ki67 expression in biopsies of patients with preneoplastic and neoplastic lesions

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 2, 2011, Pages 126-131

  Calil, Luciane Noal ^a,b   Igansi, Cristine Nascente ^c   Meurer, Luise ^b   Edelweiss, Maria Isabel Albano ^a   Bozzetti, Mary Clarisse ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Brazilian Ministry of Health Epidemiologist   (Brazil)

Author keywords

Biomarkers; Epidemiology; Human papillomavirus 16; Pharmacological

Indexed keywords

BACTERIAL DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; PROTEIN ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CELL COUNT; CERVICAL VAGINAL SWAB; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIXED INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; PAPILLOMAVIRUS INFECTION; PRECANCER; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROTEIN EXPRESSION; SAMPLING; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

EID: 79959602983     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70157-X     Document Type: Article

References (20)

1. Velicer C, Zhu X, Vuocolo S et al. Prevalence and incidence of HPV genital infection in women. Sex Transm Dis 2009; 36(11):696-703.
2. Bilardi FJ, Fairley CK, Hopkins CA et al. Experiences and Outcomes of partner notification among men and women recently diagnosed with Chlamydia and their views on innovative resources aimed at improving notification rates. Sex Transm Dis 2010; 37(4):253-258.
3. Wallin KL, Wiklund F, Luostarinen T et al. A population-based prospective study of Chlamydia trachomatis infection and cervical cancer carcinoma. Int J Cancer 2002; 101(4):371-374.
4. Doeberitz VK. New markers for cervical dysplasia to visualise the genomic chaos created by oncogenic human papillomavirus infections. Eur J Cancer 2002; 38:2229-2242.
5. Queiroz C, Silva TC, Alves VAF et al. p16INK4a and Ki67 expression as a potential prognostic marker in ceical pre-neoplastic and neoplastic lesions. Pathology Research and Practice 2006; 202:77-83.
6. Benevolo M, Mottolese M, Marandino F et al. Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006; 19(3):384-391.
7. Sarian LO, Derchain SF, Yoshida A et al. Expression of cycloxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix. Gynecologic Oncology 2006; 102(3):537-541.
8. Rosa MI, Fachel JM, Rosa DD et al. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol. 2008 Dec;199(6):617. e1-7. Epub 2008 Sep 16.
9. Becker D. Detecção de Chlamydia trachomatis em amostras cervicais por Reação em cadeia da Polimerase (Dissertação de Mestrado). Porto Alegre: Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Biologia Celular e Molecular. 2005. P. 90.
10. Bauer HM, Hildesheim A, Schiffman MH et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20(5):274-8.
11. Coutlee F, Gravitt P, Kornegay J et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002; 40(3):902-7.
12. Cuzick J, Terry G, Ho L et al. Type-specific human papillo-mavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia.Br J Cancer 1994; 69(1):167-71.
13. Bulten J, van der Avoort IA, Melchers WJ et al. p14ARF and p16INK4a, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. Gynecol Oncol 2006; 101(3):487-494.
14. Bosh FX, de San Jose S. The epidemiology of human papilomavirus infection and cervical cancer. Dis Markers 2007; 23(4):213-17.
15. De Lucca G.D, Marin H, Schelover E et al. Infeccion por Chlamydia trachomatis y Papilomavirus en mujeres con alteraciones citohistologicas de cuello uterino. Medicina (Buenos Aires) 2006; 66:303-306.
16. Denks K, Spaeth EL, Jérs K et al. Coinfection of Chlamydia trachomatis, Uresplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia. Scand J Infect Dis 2007; 39(8):714-8.
17. Franceschi S, Smith JS, Van den Brule A et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007; 34(8):563-9.
18. De Paula FD, Fernandes AP, Carmo BB et al. Molecular detection of Chlamydia trachomatis and HPV infections in cervical samples with normal and abmormal cytopathological findings. Diagn Cytopathol 2007; 35(4):198-202.
19. Naucler P, Chen NC, Persson K et al. Seroprevalence of Human Papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 2007; 88(3):814-22.
20. Fehér E, Szalmás A. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix. Acta Microbiol Immunol Hung 2006; 53(4):479-87